Aytu BioPharma, Inc. (AYTU) Earnings History
Annual and quarterly earnings data from 2007 to 2025
Loading earnings history...
AYTU EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
AYTU Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 69.0% | -11.8% | -20.4% |
| 2024 | 75.3% | -2.4% | -24.3% |
| 2023 | 62.0% | -15.9% | -15.9% |
| 2022 | 52.0% | -113.7% | -112.5% |
| 2021 | 44.5% | -89.7% | -88.8% |
Download Data
Export AYTU earnings history in CSV or JSON format
Free sign-in required to download data
Aytu BioPharma, Inc. (AYTU) Earnings Overview
As of May 8, 2026, Aytu BioPharma, Inc. (AYTU) reported trailing twelve-month net income of -$24M, reflecting +24.5% year-over-year growth. The company earned $-2.44 per diluted share over the past four quarters, with a net profit margin of -20.4%.
Looking at the long-term picture, AYTU's historical earnings data spans multiple years. The company achieved its highest annual net income of -$48,954 in fiscal 2007.
Aytu BioPharma, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SUPN (-$29M net income, -5.4% margin), TPVG (-$12M net income, 50.6% margin), ASRT (-$30M net income, -24.9% margin), AYTU has room to improve margins relative to the peer group. Compare AYTU vs SUPN →
AYTU Earnings vs Peers
Earnings metrics vs comparable public companies
AYTU Historical Earnings Data (2007–2025)
19 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$14M | +14.4% | -$8M | $-2.16 | -20.4% | -11.8% |
| 2024 | -$16M | +7.1% | -$2M | $-2.86 | -24.3% | -2.4% |
| 2023 | -$17M | +84.3% | -$17M | $-5.11 | -15.9% | -15.9% |
| 2022 | -$109M | -86.6% | -$110M | $-74.01 | -112.5% | -113.7% |
| 2021 | -$58M | -327.9% | -$59M | $-69.60 | -88.8% | -89.7% |
| 2020 | -$14M | +71.1% | -$21M | $-60.20 | -49.3% | -76.5% |
| 2019 | -$47M | -363.0% | -$17M | $-1210.28 | -644.3% | -230.1% |
| 2018 | -$10M | +54.7% | -$20M | $-3061.23 | -278.4% | -538.3% |
| 2017 | -$23M | +20.1% | -$20M | $-193194.38 | -698.7% | -624.7% |
| 2016 | -$28M | -264.9% | -$22M | $-999999.00 | -1099.7% | -847.0% |
See AYTU's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AYTU Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AYTU vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAYTU — Frequently Asked Questions
Quick answers to the most common questions about buying AYTU stock.
Is AYTU growing earnings?
AYTU EPS is $-2.44, with earnings growth accelerating to +24.5%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-24M.
What are AYTU's profit margins?
Aytu BioPharma, Inc. net margin is -20.4%, with operating margin at -11.8%. Below-average margins reflect competitive or cost pressures.
How consistent are AYTU's earnings?
AYTU earnings data spans 2007-2025. The accelerating earnings trend is +24.5% YoY. Historical data enables comparison across business cycles.